Australia markets open in 3 hours 2 minutes

Marizyme, Inc. (MRZM)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0930+0.0397 (+74.48%)
At close: 02:09PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
645.81
645.81
233.485
210.279
197.136
-
Cost of revenue
188.108
188.108
54.319
80.354
58.292
-
Gross profit
457.702
457.702
179.166
129.925
138.844
-
Operating expenses
Research development
2,177
2,177
3,979
1,682
687.734
-
Selling general and administrative
17,063
17,063
8,333
7,226
4,659
-
Total operating expenses
20,300
20,300
13,153
8,951
5,938
-
Operating income or loss
-19,842
-19,842
-12,974
-8,821
-5,800
-
Interest expense
30,224
30,224
2,789
126.024
45.45
-
Total other income/expenses net
-8,392
-8,392
-22,403
-2,051
-
-
Income before tax
-65,347
-65,347
-38,166
-10,998
-5,845
-
Income from continuing operations
-65,347
-65,347
-38,166
-10,998
-5,845
-
Net income
-65,347
-65,347
-38,166
-10,998
-5,845
-
Net income available to common shareholders
-65,347
-65,347
-38,166
-10,998
-5,845
-
Basic EPS
-1.86
-
-0.94
-0.31
-0.22
-0.05
Diluted EPS
-1.86
-
-0.94
-0.31
-0.22
-0.05
Basic average shares
42,609
-
40,727
36,042
26,374
19,806
Diluted average shares
42,609
-
40,727
36,042
26,374
19,806